Follow
Basavaraj Siddalingappa
Basavaraj Siddalingappa
Verified email at westernu.edu
Title
Cited by
Cited by
Year
Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges
S Basavaraj, GV Betageri
Acta Pharmaceutica Sinica B 4 (1), 3-17, 2014
1162014
Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol
S Basavaraj, GV Betageri
Expert opinion on drug delivery 11 (4), 493-503, 2014
652014
Development of a chitosan‐based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin
Y Chen, B Siddalingappa, PHH Chan, HAE Benson
Peptide Science 90 (5), 663-670, 2008
522008
Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability …
B Siddalingappa, HAE Benson, DH Brown, KT Batty, Y Chen
Plos one 10 (3), e0118824, 2015
262015
Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-β-cyclodextrin: selection of meglumine, a polyhydroxy base, as a …
S Basavaraj, V Sihorkar, TR Shantha Kumar, P Sundaramurthi, ...
Pharmaceutical development and technology 11 (4), 443-451, 2006
262006
Insoluble drug delivery technologies: review of health benefits and business potentials
B Siddalingappa, V Nekkanti, GV Betageri
OA Drug Design & Delivery 1 (1), 1, 2013
162013
Comparative pharmacokinetic data of DRF-4367 using nanosuspension and HP-β-CD formulation
TR Shanthakumar, S Prakash, RM Basavraj, M Ramesh, R Kant, ...
Proceedings of the International Symposium on Advances in Technology and …, 2004
132004
Application of solvent influenced fluorescence-quenching and enhancement to develop a highly sensitive HPLC methodology for analysis of resveratrol-PEG conjugates
S Basavaraj, H Ann Elizabeth Benson, D Havelock Brown, Y Chen
Current Pharmaceutical Analysis 9 (2), 199-207, 2013
82013
Development of a liquid chromatography/mass spectrometry methodology to separate, detect, characterize and quantify PEG‐resveratrol prodrugs and the conjugation reaction …
S Basavaraj, HAE Benson, C Cruickshank, DH Brown, Y Chen
Rapid Communications in Mass Spectrometry 25 (11), 1543-1551, 2011
82011
Evaluation of various processes for simultaneous complexation and granulation to incorporate drug–cyclodextrin complexes into solid dosage forms
V Gyanani, B Siddalingappa, GV Betageri
Drug Development and Industrial Pharmacy 41 (11), 1856-1863, 2015
52015
Novel formulation strategies to improve solubility and pharmacokinetic profile of Resveratrol
S Basavaraj, HAE Benson, DH Brown, Y Chen
Controlled Release Society, Product Development Forum, Poorly Soluble Drugs …, 2011
32011
The system can't perform the operation now. Try again later.
Articles 1–11